FRO人未分化甲狀腺癌細(xì)胞、F 返回列表頁

舉報(bào) 評(píng)價(jià)

參考價(jià)

面議

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品牌

廠商性質(zhì)生產(chǎn)商

所在地

在線詢價(jià) 加入對(duì)比查看聯(lián)系電話

更新時(shí)間：2025-04-24 14:52:54瀏覽次數(shù)：53次

聯(lián)系我時(shí)，請(qǐng)告知來自化工儀器網(wǎng)

同類優(yōu)質(zhì)產(chǎn)品更多>

大鼠腎足細(xì)胞

參考價(jià) 面議
McA-RH7777大鼠肝癌細(xì)

參考價(jià) 面議
SDBMSCSD大鼠骨髓間充質(zhì)

參考價(jià) 面議
DSL-6A/C1 大鼠胰腺癌

參考價(jià) 面議
Walker256-TC大鼠乳

參考價(jià) 面議

產(chǎn)品分類品牌分類

細(xì)胞庫 / 細(xì)胞培養(yǎng): 細(xì)胞系耐藥細(xì)胞株 ATCC細(xì)胞原代細(xì)胞干細(xì)胞普通細(xì)胞

全部產(chǎn)品列表

產(chǎn)品簡介

FRO人未分化甲狀腺癌細(xì)胞CatalogueNo

詳情介紹

FRO 人未分化甲狀腺癌細(xì)胞
Catalogue No.: C904
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%H-DMEM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

Item	Specifications
a T25 flask	2X10⁶
Manual	1 copy

CD8+ cells, and PD-L1+ cells were further found to be the most robust prognostic biomarkers for DFS, which were used to construct and validate the immune-related risk score for risk stratification (high vs. median vs. low) and the prediction of 5-year DFS rates (23.2% vs. 37.9% vs. 43.1%, P < 0.001). In conclusion, the intricate and intrinsic structure of TIME in NSCLC was demonstrated, showing potency in subtyping and prognostication.Gene